0001209191-24-000924.txt : 20240104
0001209191-24-000924.hdr.sgml : 20240104
20240104212727
ACCESSION NUMBER: 0001209191-24-000924
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rowland Charles A Jr
CENTRAL INDEX KEY: 0001383292
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37355
FILM NUMBER: 24514317
MAIL ADDRESS:
STREET 1: 3338 LANCASHIRE RD
CITY: FURLONG
STATE: PA
ZIP: 18925
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Viking Therapeutics, Inc.
CENTRAL INDEX KEY: 0001607678
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 461073877
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-704-4660
MAIL ADDRESS:
STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-02
0
0001607678
Viking Therapeutics, Inc.
VKTX
0001383292
Rowland Charles A Jr
C/O VIKING THERAPEUTICS, INC.
9920 PACIFIC HEIGHTS BLVD, SUITE 350
SAN DIEGO
CA
92121
1
0
0
0
0
Stock Option (Right to Buy)
18.28
2024-01-02
4
A
0
32000
0.00
A
2025-01-02
2034-01-02
Common Stock
32000
32000
D
/s/ Michael Morneau, as Attorney-in-Fact
2024-01-04